December 14, 2015 — Citing increased use of its Materialise Mimics Innovation Suite in hospitals and other clinical settings, Materialise NV announced investment in additional medical production capacity for its U.S. operations. The expansion further enables a complete range of 3-D surgical planning options to support patient-specific treatment, and the capacity to expediently provide anatomical models in the U.S. market.
[riana Smith, a 17-year-old Taylor teen, became the first patient at the Children's Hospital of Michigan, a part of the Detroit Medical Center (DMC), and the first in Michigan, to benefit from a revolutionary 3D printed heart model, produced by Materialise that helped heart specialists in selecting the right tools for her treatment]
By providing virtual planning software linked with fully integrated Materialise 3-D print services, clinicians and surgeons can use vital supplemental information to simulate or evaluate the best options for patient-specific treatment, and facilitate clear communication with patients, co-workers and/or surgical teams. Materialise HeartPrint, for instance, registered as a class 1 medical device in the United States, aids cardiovascular specialists in helping plan patient care and select the necessary tools to treat complex cases such as congenital heart surgery or aortic aneurysm interventions.
Materialise continues to evolve its Mimics Innovation Suite capabilities and has made a new version of software that caters to clinicians with a desire to use 3-D printing in their case planning. "As a beta participant for Materialise's latest medical software innovation, I have witnessed the power of their 25 years 'of experience in medical 3-D printing with this software. Materialise is clearly focused on meeting the evolving needs of clinicians, and in being the software solution for the 3D printing process in hospitals." stated Frank Rybicki, M.D., Ph.D.
For more information: www.biomedical.materialise.com
July 30, 2024 
